Moleculin Biotech Inc (NASDAQ: MBRX) flaunted slowness of -22.03% at $0.28, as the Stock market unbolted on Thursday, before settling in for the price of $0.36 at the close. Taking a more long-term approach, MBRX posted a 52-week range of $0.25-$3.65.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 26.36%. Meanwhile, its Annual Earning per share during the time was 26.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 85.68%. This publicly-traded company’s shares outstanding now amounts to $50.91 million, simultaneously with a float of $49.79 million. The organization now has a market capitalization sitting at $14.25 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4629, while the 200-day Moving Average is $0.7212.
Moleculin Biotech Inc (MBRX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Moleculin Biotech Inc industry. Moleculin Biotech Inc’s current insider ownership accounts for 2.19%, in contrast to 1.53% institutional ownership. According to the most recent insider trade that took place on Jun 23 ’25, this organization’s Chief Financial Officer bought 270,270 shares at the rate of 0.37, making the entire transaction reach 100,000 in total value, affecting insider ownership by 287,587. Preceding that transaction, on Jun 23 ’25, Company’s CEO and President bought 675,675 for 0.37, making the whole transaction’s value amount to 250,000. This particular insider is now the holder of 743,607 in total.
Moleculin Biotech Inc (MBRX) Earnings and Revenue Records
Moleculin Biotech Inc’s EPS increase for this current 12-month fiscal period is 85.68% and is forecasted to reach -0.69 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 57.07% through the next 5 years, which can be compared against the 26.36% growth it accomplished over the previous five years trading on the market.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
In the same vein, MBRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.42, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be -0.69 at the market close of one year from today.
Technical Analysis of Moleculin Biotech Inc (MBRX)
Now, what If we examine the latest scores posted by [Moleculin Biotech Inc, MBRX]. During the last 5-days, its volume was lower the volume of 4.31 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 12.12% While, its Average True Range was 17.17.
Raw Stochastic average of Moleculin Biotech Inc (MBRX) in the period of the previous 100 days is set at 2.51%, which indicates a major fall in contrast to 7.18% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0337 that was lower than 0.0554 volatility it exhibited in the past 100-days period.
